Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Cibus, Inc. before investing.

In this article, we go over a few key elements for understanding Cibus, Inc.’s stock price such as:

• Cibus, Inc.’s current stock price and volume
• Why Cibus, Inc.’s stock price changed recently
• Upgrades and downgrades for CBUS from analysts
• CBUS’s stock price momentum as measured by its relative strength

About Cibus, Inc. (CBUS)

Before we jump into Cibus, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.

Want to learn more about Cibus, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Cibus, Inc..

What Caused Cibus, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 01, 2025, there were 0 analysts who downgraded Cibus, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Cibus, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Cibus, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Cibus, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Cibus, Inc. (CBUS) by visiting AAII Stock Evaluator.

Relative Price Strength of Cibus, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 01, 2025, Cibus, Inc. has a weighted four-quarter relative price strength of -14.60%, which translates to a Momentum Score of 16 and is considered to be Very Weak.

Want to learn more about how Cibus, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Cibus, Inc. Stock Price: Bottom Line

As of December 1, 2025, Cibus, Inc.’s stock price is $1.470, which is up 8.09% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Cibus, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.